Revolocity 1 INTRODUCING INTRODUCING The Supersequencer A high-capacity, fully-integrated, sample-to-result system A complete solution
for large-scale,
high-quality WGS and
WES sequencing
End-to-end automation and workflow integration Interpretation and Reporting Platform

Genome sequencing is moving—fast

Complete Genomics is a leader in whole human genome sequencing based in Mountain View, California. Using its proprietary sequencing instruments, chemistry, and software, the company has sequenced more than 20,000 whole human genomes. The company’s mission is to improve human health by providing researchers and clinicians with the core technology and commercial systems to understand, prevent, diagnose, and treat diseases and conditions.

Over the past three years, Complete Genomics has initiated a large number of clinical utility studies designed to demonstrate that patients, payers, and physicians may be better off with a whole genome sequence as compared to standard of care. We have engaged key opinion leaders around the world to explore this question. While these studies cover many different clinical areas, three examples of the outcomes in autism, intellectual delay, and the lifetime benefit of whole genome sequencing are illustrated in these short videos.

Complete Genomics is now previewing its first commercial product, the Revolocity system. Unlike other providers who focus on providing only sequencing equipment, Complete Genomics has designed the Revolocity system to be a total end-to-end genomics solution for large-scale, high-quality genomes.